Besides the findings with COMT rs4680, the most notable result was that all arrhythmia events occurred in clinical trial 2, where the single dose of quetiapine was 50 mg, doubling the dose of clinical trial 1 (25 mg). This evidence concerns the gene COMT and cardiac arrhythmia.